Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine

US8735412B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Ulrich Lücking · Berlin, DE
• Rolf Jautelat · Haan, DE
• Gerhard Siemeister · Berlin, DE
• Julia Schulze · Berlin, DE
• Philip Lienau · Berlin, DE

Key dates

• Filing date: Oct 9, 2009
• Grant date: May 27, 2014
• Expiry date: Jun 10, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to sulfoximine-substituted anilino-pyrimidine derivatives of formula (I).methods of production thereof, and use thereof as medication for the treatment of various diseases.